Skip to content

Role of n On-contrast Chest CT (NCCT) Based CT V: Q in Patients With Acute Pulmonary Embolism (aPE)

Role of n On-contrast Chest CT (NCCT) Based CT V: Q in Patients With Acute Pulmonary Embolism (aPE)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07527117
Enrollment
750
Registered
2026-04-14
Start date
2026-07-15
Completion date
2028-12-31
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Embolism Acute, Pulmonary Embolism (Diagnosis)

Keywords

CT ventilation perfusion pulmonary embolism CT pulmonary angiogram

Brief summary

We are doing the research to see if a CT scan without the dye can help find pulmonary emboli. If you agree to join the study, you will be asked to sign this consent form before we do any research procedures. If you join the research, we will ask you to blow into a small device known as a spirometer to train you to hold your breath after you inhale and exhale. Spirometer is a small handheld device to find out how well your lungs work when you inhale and exhale. For this research, we will obtain two extra sets of CT images at very low levels of radiation dose. The two extra sets of images will take less than 1 minute. Your total participation time is about 5 minutes. We will also review your medical record for up to 30 to 90 days after your CT scan. The main risks of being in the study are exposure to ionizing radiation which may have health risks, and minor inconvenience from the spirometer test. You will not benefit from taking part in this research study. If you take part in this study, your participation may help people in the future. If you decide not to be in the study, you will still have the standard-of-care chest CT with the dye ordered by your doctor. You will not be paid for taking part in this research study.

Interventions

DIAGNOSTIC_TESTAdditional CT acquisition at low dose (1- 2 mSv)

In addition to their CTPA, we will acquire low-dose CT images in inspiration and expiration breath hold or in free breathing phase.

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients undergoing CTPA for suspected aPE 2. Patients who provide written informed consent to participate 3. Adults patients \>/= 21 years of age 4. Mini Mental State Exam (MMSE) score of 18 or more.

Exclusion criteria

1. Patients who decline informed consent 2. Patients with known chronic PE 3. Patients with known interstitial lung diseases 4. Patients who cannot raise their arms above their shoulders (arms can cause serious artifacts) 5. Women of child-bearing potential (\< 55 years) who test positive for pregnancy test 6. Patients \< 21 years of age (to avoid research radiation dose in young patients) 7. Patients with any EMR documented cognitive impairment or diseases such as dementia, recent head injury, psychiatric disorders, or other neurological diseases that impair decision-making. 8. Pregnant subjects 9. Women of child-bearing potential (21-55 years) who refuse to take a urine pregnancy test prior to their CT examination 10. Mini Mental State Exam (MMSE) score of less than 18.

Design outcomes

Primary

MeasureTime frameDescription
NPV for ruling out PE on non-contrast CT2 yearsNegative predictive value

Countries

United States

Contacts

CONTACTShivangi JHA, MD, MPH
sjha7@mgh.harvard.edu16176434583

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026